2nd Immunotherapies for Infectious Diseases 2018 – I4ID2018

2nd Immunotherapies for Infectious Diseases (I4ID2018)
10-11 December 2018 – Matmut Stadium, Lyon – France

The emergence of new infectious diseases, the re-emergence of  “old” infectious diseases, the rise of antibacterial resistance to conventional antibacterial agents and the difficulty to come out with a new pipeline of new antimicrobial  compounds leads to consider the potential of non-conventional approaches, such as immunotherapies as new therapies.

BIOASTER and MabDesign organize the 2nd edition of Immunotherapies for Infectious Diseases (I4ID) that will be held in December 10-11, 2018 in Lyon. This 2-day Congress will bring together pharmaceutical industries, research labs, clinicians, service providers, technology developers and policy makers to exchange about the development of immunotherapy solutions for prevention and treatment of infectious diseases.

The first edition gathered together more than 175 participants, 80 organizations, academics, industries, businesses and 33 internationally renowned speakers to discuss and exchange on immunotherapy as a new therapeutic way to fight emerging and or re-emerging infectious diseases, and tackle the problem of multi-resistance to antimicrobial compounds.

The program of the I4ID2018 edition will focus on Host-Directed Therapies (HDT) to fight Infectious Diseases with keynote lectures, pitch talks of new creative projects, and industrial talks from big pharmaceutical companies. Furthermore, it will be possibility to set up, through an online platform, business meetings during both days (partnering).

The topics covered during the Congress are:

  • Targeting the Immune System to fight Bacterial Infections
  • Targeting the Immune System to fight Sepsis
  • Innovation on HDT approaches to treat Infectious Diseases
  • Targeting the Immune system to fight Viral Infections
  • Bringing into clinic Host-directed therapies: safety and efficiency
  • Developing Next-Generation of host-directed therapies


  • Stefan H.Kaufmann – Institute for Infection Biology, Germany / Charité University Clinics, Germany
  • Richard Hotchkiss – Washington University School of Medicine, USA
  • Pierre-François Laterre – St Luc University Hospital, Belgium

Deadline 28th September 2018

You work in the field of infectious diseases and you have an innovation to share concerning Host-Directed Therapies or immunotherapies?
You’re part of a SME / start-up / research laboratory? You want to share your expertise?
Share your innovative products, new technologies and research projects at the Pitch SessionInnovation on HDT approaches to treat Infectious diseasesor during the Poster session! Check the guidelines to submit your abstract: http://www.i4id.org/abstracts.php
This is a great opportunity for start-ups, SMEs, and academic laboratories to share their new work!

Early Bird Registration until 5th October 2018 – register early to secure the best rates!
MabDesign members benefit of 20% discount in both Sponsoring/Exhibition and Registration rates.
Register at: http://www.i4id.org/register.php





10-11 December 2018


Matmut Stadium
Lyon, France


MabDesign & BIOASTER